Does Biological Sex Influence the Cardiac Output Response to Sprint Interval Exercise Training in Humans?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Martin Gibala, PhD
- Phone Number: 23591 905-525-9140
- Email: gibalam@mcmaster.ca
Study Contact Backup
- Name: Billy Bostad, MSc
- Email: bostadw@mcmaster.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S4K1
- McMaster University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being untrained based on a self-report of engaging in < 1 h of weekly moderate to vigorous physical activity based on the Canadian Society for Exercise Physiology Get Active Questionnaire.
- Having an estimated cardiorespiratory fitness in the lower 50% of adults in the specified age range based on the online fitness calculator available at: www.worldfitnesslevel.org.
- Females who are naturally cycling (i.e., not using any form of hormonal contraceptive) or are using a 2nd generation oral contraceptive.
Exclusion Criteria:
- Experiencing a condition that might preclude safe participation in physical activity and exercise, as determined by answering "Yes" to any question on Page 1 of the Canadian Society for Exercise Physiology Get Active Questionnaire.
- Females with a positive pregnancy test.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Females
Female participant group
|
A 10-minute sprint interval exercise training protocol that is performed three times per week for a total of 12 weeks.
|
|
Experimental: Males
Male participant group
|
A 10-minute sprint interval exercise training protocol that is performed three times per week for a total of 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak cardiac output
Time Frame: Change from baseline after 12 weeks of sprint interval exercise training
|
Peak cardiac output measured during exercise
|
Change from baseline after 12 weeks of sprint interval exercise training
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak oxygen uptake
Time Frame: Change from baseline after 12 weeks of sprint interval exercise training
|
Peak oxygen uptake measured during exercise
|
Change from baseline after 12 weeks of sprint interval exercise training
|
|
Flow mediated dilation
Time Frame: Change from baseline after 4 and 12 weeks of sprint interval exercise training
|
Brachial artery flow mediated dilation
|
Change from baseline after 4 and 12 weeks of sprint interval exercise training
|
|
Pulse wave velocity
Time Frame: Change from baseline after 4 and 12 weeks of sprint interval exercise training
|
Central and peripheral pulse wave velocity
|
Change from baseline after 4 and 12 weeks of sprint interval exercise training
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 14279
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.